The AFB Drug Susceptibility Isoniazid Monoresistance Panel (4 Drugs – LFXREZ) evaluates Mycobacterium tuberculosis resistance in cases where isoniazid resistance is suspected. Metropolis Healthcare performs this panel on pure culture isolates to determine susceptibility to Levofloxacin (LFX), Rifampicin (R), Ethambutol (E), and Pyrazinamide (Z). This helps guide appropriate treatment modifications for INH-resistant TB.
Price:
Rs. 6,150.00
Sample Type: (Mtb Complex) Bottle , LJ slant , MGIT Tube
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the Isoniazid Monoresistance Panel at Metropolis Healthcare include?
It assesses TB bacteria against four key drugs—Levofloxacin, Rifampicin, Ethambutol, and Pyrazinamide—to evaluate resistance when INH resistance is suspected.
How does Metropolis Healthcare perform this DST test?
Pure culture isolates undergo validated culture-based drug susceptibility testing under strict biosafety and quality systems.
Who should undergo this Isoniazid monoresistance panel?
Patients with confirmed TB showing suspected or known isoniazid resistance, treatment failure, or relapse should consider this test.
Why is this panel important for INH-resistant TB?
It helps identify effective alternative drugs and prevents treatment failure by avoiding medications that the TB strain resists.
Why must the test be done on a pure culture isolate?
Pure cultures ensure accurate drug response measurements and eliminate contamination or mixed-strain interference.
How do the results help clinicians?
They guide optimised therapy by showing which drugs remain effective despite isoniazid resistance.
Is any patient preparation required?
No preparation is needed; only a confirmed pure culture isolate is required from the referring lab.
How long does Metropolis Healthcare take to provide results?
As a culture-based test, results typically take several weeks depending on bacterial growth characteristics.